151 related articles for article (PubMed ID: 2384837)
21. Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer.
Yüksel N; Baykara T
J Microencapsul; 1997; 14(6):725-33. PubMed ID: 9394253
[TBL] [Abstract][Full Text] [Related]
22. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine.
Hashimoto Y; Tanaka M; Kishimoto H; Shiozawa H; Hasegawa K; Matsuyama K; Uchida T
J Pharm Pharmacol; 2002 Oct; 54(10):1323-8. PubMed ID: 12396292
[TBL] [Abstract][Full Text] [Related]
24. Thymosin-loaded enteric microspheres for oral administration: preparation and in vitro release studies.
Yang JF; Qiu LY; Jin Y; Zhang JX
Int J Pharm; 2005 Sep; 301(1-2):41-7. PubMed ID: 16009514
[TBL] [Abstract][Full Text] [Related]
25. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.
Aliabadi HM; Elhasi S; Mahmud A; Gulamhusein R; Mahdipoor P; Lavasanifar A
Int J Pharm; 2007 Feb; 329(1-2):158-65. PubMed ID: 17008034
[TBL] [Abstract][Full Text] [Related]
26. Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine.
Mandal TK; Shekleton M; Onyebueke E; Washington L; Penson T
J Microencapsul; 1996; 13(5):545-57. PubMed ID: 8864992
[TBL] [Abstract][Full Text] [Related]
27. Oil-in-oil microencapsulation technique with an external perfluorohexane phase.
Mana Z; Pellequer Y; Lamprecht A
Int J Pharm; 2007 Jun; 338(1-2):231-7. PubMed ID: 17368983
[TBL] [Abstract][Full Text] [Related]
28. The development of colour-encapsulated microspheres for novel colour cosmetics.
Jones SR; Grey BD; Mistry KK; Wildgust PG
J Microencapsul; 2009 Jun; 26(4):325-33. PubMed ID: 18686145
[TBL] [Abstract][Full Text] [Related]
29. Preparation of microspheres of water-soluble pharmaceuticals.
Huang HP; Ghebre-Sellassie I
J Microencapsul; 1989; 6(2):219-25. PubMed ID: 2723966
[TBL] [Abstract][Full Text] [Related]
30. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
Rawat M; Saraf S
J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
[TBL] [Abstract][Full Text] [Related]
31. Determination of poly(epsilon-caprolactone) solubility parameters: application to solvent substitution in a microencapsulation process.
Bordes C; Fréville V; Ruffin E; Marote P; Gauvrit JY; Briançon S; Lantéri P
Int J Pharm; 2010 Jan; 383(1-2):236-43. PubMed ID: 19781605
[TBL] [Abstract][Full Text] [Related]
32. Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.
Freytag T; Dashevsky A; Tillman L; Hardee GE; Bodmeier R
J Control Release; 2000 Oct; 69(1):197-207. PubMed ID: 11018557
[TBL] [Abstract][Full Text] [Related]
33. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles.
Srinivasan C; Katare YK; Muthukumaran T; Panda AK
J Microencapsul; 2005 Mar; 22(2):127-38. PubMed ID: 16019899
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and performance evaluation of neomycin-HSA microspheres.
Pande S; Vyas S; Dixit V
J Microencapsul; 1990; 7(2):155-65. PubMed ID: 2329442
[TBL] [Abstract][Full Text] [Related]
35. Role of the solvent-diffusion-rate modifier in a new emulsion solvent diffusion method for preparation of ketoprofen microspheres.
Kawashima Y; Iwamoto T; Niwa T; Takeuchi H; Hino T
J Microencapsul; 1993; 10(3):329-40. PubMed ID: 8377091
[TBL] [Abstract][Full Text] [Related]
36. Studies on microencapsulation of 5-fluorouracil with poly(ortho ester) polymers.
Lin YH; Vasavada RC
J Microencapsul; 2000; 17(1):1-11. PubMed ID: 10670936
[TBL] [Abstract][Full Text] [Related]
37. Low molecular weight heparin loaded pH-sensitive microparticles.
Meissner Y; Ubrich N; Ghazouani FE; Maincent P; Lamprecht A
Int J Pharm; 2007 Apr; 335(1-2):147-153. PubMed ID: 17150317
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of solvent evaporation encapsulation processes: prediction of solvent evaporation rate.
Wang J; Schwendeman SP
J Pharm Sci; 1999 Oct; 88(10):1090-9. PubMed ID: 10514360
[TBL] [Abstract][Full Text] [Related]
39. Application of Hansen solubility parameters for understanding and prediction of drug distribution in microspheres.
Vay K; Scheler S; Friess W
Int J Pharm; 2011 Sep; 416(1):202-9. PubMed ID: 21745557
[TBL] [Abstract][Full Text] [Related]
40. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique.
Dinarvand R; Moghadam SH; Sheikhi A; Atyabi F
J Microencapsul; 2005 Mar; 22(2):139-51. PubMed ID: 16019900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
